Government

Rate Setting Not Market-based and Circumvents Legislative Intent SAN DIEGO, Calif., Sept. 25, 2017 /PRNewswire/ -- XIFIN, Inc., the healthcare information technology company revolutionizing the business of healthcare...

By Christopher Ivicevich, Director of Regulatory Affairs & Quality Compliance, OptraSCAN With the recent shift in the industry as the result of this decision, a common question is “What lies in store for digital pathology system...

Promega Corporation intends to seek FDA approval and CE-IVD marking for a commercially available Microsatellite Instability (MSI) assay to assist oncologists and pathologists in determining colorectal cancer decisions. The current Promega...

I recently had an opportunity to speak with Esther Abels, Director of Regulatory, Clinical and Medical Affairs for Philips Digital Pathology Solutions about Philips’ recent approval to market their Philips Intellisite Pathology System (PIPS)...

Tuesday, June 13th, Philips Digital Pathology Solutions will host two webinars for: North America: 10:00 AM - 11:00 AM EDT Register Asia & Europe: 3:00 PM - 4:00 PM SGT Register Philips IntelliSite Pathology Solution is now...

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have...